DDR2 is critical in bladder cancer progression, affecting proliferation, migration, invasion, metastasis, EMT, and chemotherapy resistance, and its abnormal expression and mutations are linked to aggressive cancer phenotypes, highlighting its potential as a therapeutic target [57, 58]. Here, DDR2 is linked to cancer.